Zobrazeno 1 - 10
of 63
pro vyhledávání: '"D. Titton"'
Autor:
José Caetano Macieira, Marcelo de Medeiros Pinheiro, Roberto Ranza, Laurindo Ferreira da Rocha, Aline Ranzolin, Ivânio Alves Pereira, Sergio Kowalski, Fabiana Pompeo de Pina, Ângela Luzia Branco Pinto Duarte, Bárbara Stadler Kahlow, Markus Bredemeier, Cristiano Michelini Lupo, Deborah Negrão Gonçalo Dias, Maria de Fátima Lobato da Cunha Sauma, Paulo Louzada-Junior, Morgana Ohira Gazzeta, Rafael Mendonça Silva da Chakr, Reginaldo Botelho Teodoro, Adriana Maria Kakehasi, Ieda Maria Magalhães Laurindo, Gláucio Ricardo Werner de Castro, Samia Araujo de Souza Studart, Vander Fernandes, Manoel Barros Bertolo, Claiton Viegas Brenol, José Roberto Silva Miranda, Ana Cristina de Medeiros Ribeiro, D. Titton, Geraldo da Rocha Castelar Pinheiro, Hellen M.S. Carvalho, Inês Guimarães da Silveira, Valéria Valim Cristo, Lidia Balarini, Ricardo Machado Xavier, André Luiz Shinji Hayata
Publikováno v:
SBR 2021 Congresso Brasileiro de Reumatologia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90787dd0cefeab3a8522bbe61d762ef7
https://doi.org/10.47660/cbr.2021.2143
https://doi.org/10.47660/cbr.2021.2143
Autor:
R. Chakr, M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira De Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, I. Pereira, H. De Leon de Lima, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, C. Lupo, L. Balarini, I. Silveira, S. Schowalski, D. Titton, A. Ranzolin, I. Laurindo, R. Xavier
Publikováno v:
Annals of the Rheumatic Diseases. 81:596.2-597
BackgroundThe effect of age on persistence and safety of treatment with biologic disease modifying anti-rheumatic drugs (bDMARDs) in rheumatoid arthritis has been a subject to research interest. Two recently published studies did not observe signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db6af5613ed73ce4ed7201a921fa6faa
https://doi.org/10.1136/annrheumdis-2022-eular.2706
https://doi.org/10.1136/annrheumdis-2022-eular.2706
Autor:
M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier
Publikováno v:
Annals of the Rheumatic Diseases. 81:360.2-361
BackgroundAntimalarials (AM) are frequently part of the initial scheme of conventional synthetic DMARDs in the treatment of rheumatoid arthritis (RA), and have been associated with lower incidence of diabetes and better lipid profile in these patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ceb18110f322c04db0a32d4ddf73805
https://doi.org/10.1136/annrheumdis-2022-eular.4120
https://doi.org/10.1136/annrheumdis-2022-eular.4120
Autor:
S. M M de Souza, A. C. Medeiros-Ribeiro, M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier
Publikováno v:
Annals of the Rheumatic Diseases. 81:1701.3-1702
BackgroundThe SARS-CoV-2 virus has caused a worldwide health crisis. Patients with inflammatory arthritis are at higher risk of hospitalization and death by COVID-19 due to comorbidities or immunosuppressive treatments. Vaccination is one the most im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9870f5ed931b4376d32fb010ace9fcd
https://doi.org/10.1136/annrheumdis-2022-eular.4722
https://doi.org/10.1136/annrheumdis-2022-eular.4722
Autor:
M. Pinheiro, José Roberto Provenza, Ieda Maria Magalhães Laurindo, Washington A. Bianchi, João Luiz de Miranda, Ana Paula Medeiros, Valeria Valim, P. Louzada, Daniel Feldman, F Sauma, R Botelho, Liana L. Carvalho, S Schowalski, Samia Araujo De Sousa Studart, Manoel Barros Bertolo, Adriana Maria Kakehasi, Claiton Viegas Brenol, B. Stadler, G. Castelar, Hellen M.S. Carvalho, D. Titton, Gláucio Ricardo Werner de Castro, Roberto Ranza, Vander Fernandes, Markus Bredemeier, H. Resende, M Gazzeta, R Acayaba, J. K. Amaral, Ivânio Alves Pereira, Lívia G. Rocha, A. Duarte, C Macieira, Inês Guimarães da Silveira, Aline Ranzolin, André Luiz Shinji Hayata
Publikováno v:
SATURDAY, 15 JUNE 2019.
Background: As Brazil is accountable for 33% of the tuberculosis (TB) burden in Americas, with an annual incidence of 33.5/100,000 in 2017[1], the occurrence of tuberculosis infection in patients with rheumatic diseases in use of biological therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::473d7d30b8ef514963a287db2bab3556
https://doi.org/10.1136/annrheumdis-2019-eular.4624
https://doi.org/10.1136/annrheumdis-2019-eular.4624
Autor:
Ivânio Alves Pereira, Manoel Barros Bertolo, Claiton Viegas Brenol, Ieda Maria Magalhães Laurindo, Vander Fernandes, R Botelho, B. Stadler, André Luiz Shinji Hayata, Hellen M.S. Carvalho, Valeria Valim, P. Louzada, Roberto Ranza, F Sauma, Aline Ranzolin, José Roberto Provenza, C Macieira, João Luiz de Miranda, M. Pinheiro, A. Duarte, S Schowalski, D. Titton, Daniel Feldman, Inês Guimarães da Silveira, Ana Paula Medeiros, Markus Bredemeier, Gláucio Ricardo Werner de Castro
Publikováno v:
Poster Presentations.
Background The combination of methotrexate (MTX) with leflunomide (LEF), despite being effective in the therapy of rheumatoid arthritis (RA)[1], has not been widely accepted[2,3]. In spite of evidence that the MTX-LEF combination is generally safe [1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b00a2ce24bfbb3433ec8a32ac91e7b37
https://doi.org/10.1136/annrheumdis-2019-eular.3867
https://doi.org/10.1136/annrheumdis-2019-eular.3867
Autor:
Daniel Feldman, Aline Ranzolin, A Acayaba, Gláucio Ricardo Werner de Castro, José Roberto Provenza, Markus Bredemeier, R Botelho, Jorge Miguel Miranda, Laurindo Ferreira da Rocha, Lidiane Oliveira de Carvalho, D. Titton, A Medeiros Ribeiro, Washington A. Bianchi, G. Castelar, Angela Luzia Branco Pinto Duarte, Vander Fernandes, Hellen M.S. Carvalho, André Luiz Shinji Hayata, M.L. Pinheiro, Roberto Ranza, C Macieira, Ieda Maria Magalhães Laurindo, Ivânio Alves Pereira, Manoel Barros Bertolo, Claiton Viegas Brenol, Morgana Ohira Gazzeta, Valeria Valim, Joana S. Amaral, S. Studart, Inês Guimarães da Silveira, S Schowalski, Paulo Roberto Louzada, F Sauma, B. Stadler, Adriana Maria Kakehasi, H. Resende
Publikováno v:
Blucher Medical Proceedings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebb825debcc59abadcb710a3f4a28707
https://doi.org/10.5151/sbr2019-577
https://doi.org/10.5151/sbr2019-577
Autor:
D. Negrão Gonçalo Dias, D. Titton, R. Xavier, G.da R.C. Pinheiro, M. Pinheiro, Ieda Maria Magalhães Laurindo, L. Balarini, José Caetano Macieira, Fabiana Pompeo de Pina, Manoel Barros Bertolo, M. Ohira Gazzeta, Markus Bredemeier, Cristiano Michelini Lupo, Roberto Ranza, Valeria Valim, P. Louzada, A. Maria Kakehasi, Lívia G. Rocha, Claiton Viegas Brenol, Vander Fernandes, Maria de Fátima Lobato da Cunha Sauma, S. Studart, R Botelho, Hellen M.S. Carvalho, Ana Paula Medeiros, Ivânio Alves Pereira, Gláucio Ricardo Werner de Castro, Inês Guimarães da Silveira, João Luiz de Miranda, Aline Ranzolin, B. Stadler, Sergio Kowalski, A. Duarte, André Luiz Shinji Hayata, R. Chakr
Publikováno v:
Annals of the Rheumatic Diseases. 80:582.2-583
Background:After failure of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) in the therapy of rheumatoid arthritis (RA), treatment may be escalated to biologic (bDMARDs) or JAK inhibitors (JAKi) (1). Analysis of drug survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80ede3938828b2943eb873edc00b27b9
https://doi.org/10.1136/annrheumdis-2021-eular.3841
https://doi.org/10.1136/annrheumdis-2021-eular.3841
Autor:
M.D.F. Lobato, G. Castelar, A. Hayata, J. Miranda, G. Christopoulos, H. Carvalho, Washington A. Bianchi, J. Moraes, B. Kahlow, Roberto Ranza, G. Castro, Manoel Barros Bertolo, Ivânio Alves Pereira, R. Teodoro, Izaias Pereira da Costa, Claiton Viegas Brenol, D. Titton, R. Toledo, J. Macieira, A. Ranzoline, I. Silva, Valeria Valim, A. Duarte, P. Louzada, M. Pinheiro, V. Fernandes, Ieda Maria Magalhães Laurindo, Adriana Maria Kakehasi
Publikováno v:
Rheumatoid arthritis – prognosis, predictors and outcome.
Objectives to analyse disease activity of RA patients at the start of treatment with a biologic agent (adalimumab, infliximab, certolizumab, etanercept, golimumab, abatacept, rituximab and tocilizumab -bDMARDs), target (tofacitinib-tsDMARDs) therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57ec9b50df5e51853dc59a89be3e70ab
https://doi.org/10.1136/annrheumdis-2018-eular.6154
https://doi.org/10.1136/annrheumdis-2018-eular.6154
Autor:
J. Maciera, J. Moraes, D. Titton, Manoel Barros Bertolo, Ivânio Alves Pereira, Claiton Viegas Brenol, G. Castro, M. Freire, H. Carvalho, V. Fernandes, M. Sauma, Ieda Maria Magalhães Laurindo, Roberto Ranza, B. Stadler, Geraldo da Rocha Castelar Pinheiro, M. Bustamante, J. Miranda, Izaias Pereira da Costa, Miguel Ángel Descalzo, A. Duarte, Valeria Valim, P. Louzada, R. Toledo, C. Baaklini, Washington A. Bianchi
Publikováno v:
Annals of the Rheumatic Diseases. 75:422.1-422
Background The safety profile of biologic drugs might have substantial regional differences. Since 2009, the Brazilian Society of Rheumatology runs BiobadaBrasil, a registry for monitoring of biologic therapies in rheumatic diseases, in collaboration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58a2879fd25500a9d6899f5652b2e1a0
https://doi.org/10.1136/annrheumdis-2016-eular.1560
https://doi.org/10.1136/annrheumdis-2016-eular.1560